1.   In advanced breast cancer, chemotherapy has been shown to improve both quality of life and conventional endpoints, and in such circumstances treatment can readily be advised.

2.   An advisory panel recommended that the Food and Drug Administration approve two new drugs designed to give women with advanced breast cancer more options for treatment.

3.   An FDA advisory panel also recommends approval of a Hoffman LaRoche drug that promises to help shrink the tumors of women with advanced breast cancer.

4.   Because it is already approved for use in advanced breast cancer and ovarian cancer, doctors can legally use it for early-stage disease as well.

5.   Both were participating in a study involving high doses of chemotherapy for advanced breast cancer.

6.   About one-quarter of the cases diagnosed each year are considered advanced breast cancer.

7.   But four major clinical trials reported last May found that women with advanced breast cancer who were given bone marrow transplants fared no better than women given conventional chemotherapy.

8.   Contrary to popular opinion, support groups do not extend the lives of women with advanced breast cancer, according to a large study being published on Thursday.

9.   FDA Clears Breast-Cancer Drug The Food and Drug Administration approved Herceptin, a genetically engineered drug developed by Genentech, for the treatment of advanced breast cancer.

10.   For the last decade, doctors have treated advanced breast cancer through a procedure called autologous bone marrow transplantation.